APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Blockchain In Pharmaceutical

The global Blockchain in Pharmaceutical market size is projected to reach US$ 30519 million by 2026, from US$ 1010.2 million in 2019, at a CAGR of 72.77% during 2021-2026.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

The global Blockchain in Pharmaceutical market size is projected to reach US$ 30519 million by 2026, from US$ 1010.2 million in 2019, at a CAGR of 72.77% during 2021-2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Blockchain in Pharmaceutical market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Blockchain in Pharmaceutical market in terms of revenue.

Selected research

Market Outlook & Growth Opportunities

Global Blockchain In Pharmaceutical Market Outlook and Growth Opportunities 2026

28 December 2025191 pages

Choose your research edition.

Industry ResearchBlockchain In Pharmaceutical Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Blockchain In Pharmaceutical Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Blockchain In Pharmaceutical Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Blockchain In Pharmaceutical Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Blockchain In Pharmaceutical Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Blockchain in Pharmaceutical market size is projected to reach US$ 30519 million by 2026, from US$ 1010.2 million in 2019, at a CAGR of 72.77% during 2021-2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Blockchain in Pharmaceutical market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Blockchain in Pharmaceutical market in terms of revenue.

Among the different types of blockchain in pharmaceutical, the private blockchain held the maximum market share with about 91% in 2019.

Read the full market overview

For applications of the blockchain in pharmaceutical, the supply chain logistics is the largest segment with a market share of nearly 69% in 2019.

This report provides an overview of the global Blockchain In Pharmaceutical market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Blockchain In Pharmaceutical and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Blockchain In Pharmaceutical revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Blockchain In Pharmaceutical market.

Blockchain In Pharmaceutical Segment by Company

IBM

AWS

Microsoft

SAP

Chronicled

Embleema

FarmaTrust

Guardtime Federal

Blockchain In Pharmaceutical Segment by Type

Private Blockchain

Hybrid Blockchain

Blockchain In Pharmaceutical Segment by Application

Supply Chain Logistics

Drug Safety

Clinical Trial Management

IOMT & Cyber Security

Blockchain In Pharmaceutical Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Blockchain In Pharmaceutical status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Blockchain In Pharmaceutical key companies, revenue, market share, and recent developments.

3. To split the Blockchain In Pharmaceutical breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Blockchain In Pharmaceutical market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Blockchain In Pharmaceutical significant trends, drivers, influence factors in global and regions.

6. To analyze Blockchain In Pharmaceutical competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blockchain In Pharmaceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Blockchain In Pharmaceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blockchain In Pharmaceutical.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Blockchain In Pharmaceutical industry.

Chapter 3: Detailed analysis of Blockchain In Pharmaceutical company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Blockchain In Pharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Blockchain In Pharmaceutical in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Blockchain In Pharmaceutical Industry Trends Table 2. Blockchain In Pharmaceutical Industry Drivers Table 3. Blockchain In Pharmaceutical Industry Opportunities and Challenges Table 4. Blockchain In Pharmaceutical Industry Restraints Table 5. Global Blockchain In Pharmaceutical Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Blockchain In Pharmaceutical Revenue Share by Company (2021-2026) Table 7. Global Blockchain In Pharmaceutical Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Blockchain In Pharmaceutical Key Company Manufacturing Base & Headquarters Table 9. Global Blockchain In Pharmaceutical Company, Product Type & Application Table 10. Global Blockchain In Pharmaceutical Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Blockchain In Pharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Private Blockchain Table 15. Significant Companies of Hybrid Blockchain Table 16. Global Blockchain In Pharmaceutical Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Blockchain In Pharmaceutical Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Blockchain In Pharmaceutical Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Blockchain In Pharmaceutical Sales Value Share by Type (2021-2026) Table 20. Global Blockchain In Pharmaceutical Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Supply Chain Logistics Table 22. Significant Companies of Drug Safety Table 23. Significant Companies of Clinical Trial Management Table 24. Significant Companies of IOMT & Cyber Security Table 25. Global Blockchain In Pharmaceutical Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Blockchain In Pharmaceutical Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Blockchain In Pharmaceutical Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Blockchain In Pharmaceutical Sales Value Share by Application (2021-2026) Table 29. Global Blockchain In Pharmaceutical Sales Value Share by Application (2027-2032) Table 30. Global Blockchain In Pharmaceutical Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Blockchain In Pharmaceutical Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Blockchain In Pharmaceutical Sales Value Share by Region (2021-2026) Table 33. Global Blockchain In Pharmaceutical Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Blockchain In Pharmaceutical Sales Value Share by Region (2027-2032) Table 35. Global Blockchain In Pharmaceutical Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Blockchain In Pharmaceutical Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Blockchain In Pharmaceutical Sales Value Market Share by Country (2021-2026) Table 38. Global Blockchain In Pharmaceutical Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Blockchain In Pharmaceutical Sales Value Market Share by Country (2027-2032) Table 40. IBM Company Information Table 41. IBM Business Overview Table 42. IBM Blockchain In Pharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. IBM Blockchain In Pharmaceutical Product Portfolio Table 44. IBM Recent Development Table 45. AWS Company Information Table 46. AWS Business Overview Table 47. AWS Blockchain In Pharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. AWS Blockchain In Pharmaceutical Product Portfolio Table 49. AWS Recent Development Table 50. Microsoft Company Information Table 51. Microsoft Business Overview Table 52. Microsoft Blockchain In Pharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Microsoft Blockchain In Pharmaceutical Product Portfolio Table 54. Microsoft Recent Development Table 55. SAP Company Information Table 56. SAP Business Overview Table 57. SAP Blockchain In Pharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. SAP Blockchain In Pharmaceutical Product Portfolio Table 59. SAP Recent Development Table 60. Chronicled Company Information Table 61. Chronicled Business Overview Table 62. Chronicled Blockchain In Pharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Chronicled Blockchain In Pharmaceutical Product Portfolio Table 64. Chronicled Recent Development Table 65. Embleema Company Information Table 66. Embleema Business Overview Table 67. Embleema Blockchain In Pharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Embleema Blockchain In Pharmaceutical Product Portfolio Table 69. Embleema Recent Development Table 70. FarmaTrust Company Information Table 71. FarmaTrust Business Overview Table 72. FarmaTrust Blockchain In Pharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. FarmaTrust Blockchain In Pharmaceutical Product Portfolio Table 74. FarmaTrust Recent Development Table 75. Guardtime Federal Company Information Table 76. Guardtime Federal Business Overview Table 77. Guardtime Federal Blockchain In Pharmaceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Guardtime Federal Blockchain In Pharmaceutical Product Portfolio Table 79. Guardtime Federal Recent Development Table 80. Research Programs/Design for This Report Table 81. Authors List of This Report Table 82. Secondary Sources Table 83. Primary Sources List of Figures Figure 1. Blockchain In Pharmaceutical Product Image Figure 2. Global Blockchain In Pharmaceutical Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Blockchain In Pharmaceutical Market Size (2021-2032) & (US$ Million) Figure 4. Global Blockchain In Pharmaceutical Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Private Blockchain Image Figure 8. Hybrid Blockchain Image Figure 9. Global Blockchain In Pharmaceutical Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Blockchain In Pharmaceutical Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Blockchain In Pharmaceutical Sales Value Share by Type (2021-2032) Figure 12. Supply Chain Logistics Image Figure 13. Drug Safety Image Figure 14. Clinical Trial Management Image Figure 15. IOMT & Cyber Security Image Figure 16. Global Blockchain In Pharmaceutical Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Blockchain In Pharmaceutical Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Blockchain In Pharmaceutical Sales Value Share by Application (2021-2032) Figure 19. Global Blockchain In Pharmaceutical Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Blockchain In Pharmaceutical Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Blockchain In Pharmaceutical Sales Value (2021-2032) & (US$ Million) Figure 22. North America Blockchain In Pharmaceutical Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Blockchain In Pharmaceutical Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Blockchain In Pharmaceutical Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Blockchain In Pharmaceutical Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Blockchain In Pharmaceutical Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Blockchain In Pharmaceutical Sales Value (2021-2032) & (US$ Million) Figure 28. South America Blockchain In Pharmaceutical Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Blockchain In Pharmaceutical Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Blockchain In Pharmaceutical Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Private Blockchain
  • Hybrid Blockchain
Applications
  • Supply Chain Logistics
  • Drug Safety
  • Clinical Trial Management
  • IOMT & Cyber Security
Companies covered
  • IBM
  • AWS
  • Microsoft
  • SAP
  • Chronicled
  • Embleema
  • FarmaTrust
  • Guardtime Federal

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Blockchain In Pharmaceutical Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Blockchain In Pharmaceutical Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Blockchain In Pharmaceutical Market Dynamics
  1. 2.1 Blockchain In Pharmaceutical Industry Trends
  2. 2.2 Blockchain In Pharmaceutical Industry Drivers
  3. 2.3 Blockchain In Pharmaceutical Industry Opportunities and Challenges
  4. 2.4 Blockchain In Pharmaceutical Industry Restraints
3 Blockchain In Pharmaceutical Market by Company
  1. 3.1 Global Blockchain In Pharmaceutical Company Revenue Ranking in 2025
  2. 3.2 Global Blockchain In Pharmaceutical Revenue by Company (2021-2026)
  3. 3.3 Global Blockchain In Pharmaceutical Company Ranking (2024-2026)
  4. 3.4 Global Blockchain In Pharmaceutical Company Manufacturing Base and Headquarters
  5. 3.5 Global Blockchain In Pharmaceutical Company Product Type and Application
  6. 3.6 Global Blockchain In Pharmaceutical Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Blockchain In Pharmaceutical Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Blockchain In Pharmaceutical Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Blockchain In Pharmaceutical Market by Type
  1. 4.1 Blockchain In Pharmaceutical Type Introduction
  2. 4.1.1 Private Blockchain
  3. 4.1.2 Hybrid Blockchain
  4. 4.2 Global Blockchain In Pharmaceutical Sales Value by Type
  5. 4.2.1 Global Blockchain In Pharmaceutical Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Blockchain In Pharmaceutical Sales Value by Type (2021-2032)
  7. 4.2.3 Global Blockchain In Pharmaceutical Sales Value Share by Type (2021-2032)
5 Blockchain In Pharmaceutical Market by Application
  1. 5.1 Blockchain In Pharmaceutical Application Introduction
  2. 5.1.1 Supply Chain Logistics
  3. 5.1.2 Drug Safety
  4. 5.1.3 Clinical Trial Management
  5. 5.1.4 IOMT & Cyber Security
  6. 5.2 Global Blockchain In Pharmaceutical Sales Value by Application
  7. 5.2.1 Global Blockchain In Pharmaceutical Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Blockchain In Pharmaceutical Sales Value by Application (2021-2032)
  9. 5.2.3 Global Blockchain In Pharmaceutical Sales Value Share by Application (2021-2032)
6 Blockchain In Pharmaceutical Regional Value Analysis
  1. 6.1 Global Blockchain In Pharmaceutical Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Blockchain In Pharmaceutical Sales Value by Region (2021-2032)
  3. 6.2.1 Global Blockchain In Pharmaceutical Sales Value by Region: 2021-2026
  4. 6.2.2 Global Blockchain In Pharmaceutical Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Blockchain In Pharmaceutical Sales Value (2021-2032)
  7. 6.3.2 North America Blockchain In Pharmaceutical Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Blockchain In Pharmaceutical Sales Value (2021-2032)
  10. 6.4.2 Europe Blockchain In Pharmaceutical Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Blockchain In Pharmaceutical Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Blockchain In Pharmaceutical Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Blockchain In Pharmaceutical Sales Value (2021-2032)
  16. 6.6.2 South America Blockchain In Pharmaceutical Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Blockchain In Pharmaceutical Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Blockchain In Pharmaceutical Sales Value Share by Country, 2025 VS 2032
7 Blockchain In Pharmaceutical Country-level Value Analysis
  1. 7.1 Global Blockchain In Pharmaceutical Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Blockchain In Pharmaceutical Sales Value by Country (2021-2032)
  3. 7.2.1 Global Blockchain In Pharmaceutical Sales Value by Country (2021-2026)
  4. 7.2.2 Global Blockchain In Pharmaceutical Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Blockchain In Pharmaceutical Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Blockchain In Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Blockchain In Pharmaceutical Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 IBM
  2. 8.1.1 IBM Company Information
  3. 8.1.2 IBM Business Overview
  4. 8.1.3 IBM Blockchain In Pharmaceutical Revenue and Gross Margin (2021-2026)
  5. 8.1.4 IBM Blockchain In Pharmaceutical Product Portfolio
  6. 8.1.5 IBM Recent Developments
  7. 8.2 AWS
  8. 8.2.1 AWS Company Information
  9. 8.2.2 AWS Business Overview
  10. 8.2.3 AWS Blockchain In Pharmaceutical Revenue and Gross Margin (2021-2026)
  11. 8.2.4 AWS Blockchain In Pharmaceutical Product Portfolio
  12. 8.2.5 AWS Recent Developments
  13. 8.3 Microsoft
  14. 8.3.1 Microsoft Company Information
  15. 8.3.2 Microsoft Business Overview
  16. 8.3.3 Microsoft Blockchain In Pharmaceutical Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Microsoft Blockchain In Pharmaceutical Product Portfolio
  18. 8.3.5 Microsoft Recent Developments
  19. 8.4 SAP
  20. 8.4.1 SAP Company Information
  21. 8.4.2 SAP Business Overview
  22. 8.4.3 SAP Blockchain In Pharmaceutical Revenue and Gross Margin (2021-2026)
  23. 8.4.4 SAP Blockchain In Pharmaceutical Product Portfolio
  24. 8.4.5 SAP Recent Developments
  25. 8.5 Chronicled
  26. 8.5.1 Chronicled Company Information
  27. 8.5.2 Chronicled Business Overview
  28. 8.5.3 Chronicled Blockchain In Pharmaceutical Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Chronicled Blockchain In Pharmaceutical Product Portfolio
  30. 8.5.5 Chronicled Recent Developments
  31. 8.6 Embleema
  32. 8.6.1 Embleema Company Information
  33. 8.6.2 Embleema Business Overview
  34. 8.6.3 Embleema Blockchain In Pharmaceutical Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Embleema Blockchain In Pharmaceutical Product Portfolio
  36. 8.6.5 Embleema Recent Developments
  37. 8.7 FarmaTrust
  38. 8.7.1 FarmaTrust Company Information
  39. 8.7.2 FarmaTrust Business Overview
  40. 8.7.3 FarmaTrust Blockchain In Pharmaceutical Revenue and Gross Margin (2021-2026)
  41. 8.7.4 FarmaTrust Blockchain In Pharmaceutical Product Portfolio
  42. 8.7.5 FarmaTrust Recent Developments
  43. 8.8 Guardtime Federal
  44. 8.8.1 Guardtime Federal Company Information
  45. 8.8.2 Guardtime Federal Business Overview
  46. 8.8.3 Guardtime Federal Blockchain In Pharmaceutical Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Guardtime Federal Blockchain In Pharmaceutical Product Portfolio
  48. 8.8.5 Guardtime Federal Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst